Co-expression of anti-rotavirus proteins (llama VHH antibody fragments) in Lactobacillus: Development and functionality of vectors containing two expression cassettes in tandem

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Günaydin, Gökçe ^a   Álvarez, Beatriz ^a   Lin, Yin ^a   Hammarström, Lennart ^a   Marcotte, Harold ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN ANTIBODY; ROTAVIRUS PROTEIN 1 ANTIBODY; ROTAVIRUS PROTEIN 3 ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EXPRESSION VECTOR; FLOW CYTOMETRY; LACTOBACILLUS PARACASEI; NONHUMAN; ROTAVIRUS; VIRUS STRAIN; WESTERN BLOTTING;

ANIMALS; CAMELIDS, NEW WORLD; CHILD; GENE EXPRESSION; GENETIC VECTORS; HUMANS; LACTOBACILLUS; ROTAVIRUS; ROTAVIRUS INFECTIONS; SINGLE-DOMAIN ANTIBODIES; VIRAL PROTEINS;

EID: 84899721877     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096409     Document Type: Article

References (28)

1. Greenberg HB, Estes MK (2009) Rotaviruses: from pathogenesis to vaccination. Gastroenterology 136: 1939-1951.
2. You D, Wardlaw T, Salama P, Jones G (2010) Levels and trends in under-5 mortality, 1990-2008. Lancet 375: 100-103.
3. Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, et al. (2007) Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 370: 1757-1763. (Pubitemid 350137490)
4. Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, et al. (2010) Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 362: 289-298.
5. de Palma O, Cruz L, Ramos H, de Baires A, Villatoro N, et al. (2010) Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. BMJ 340: c2825.
6. Patel M, Pedreira C, De Oliveira LH, Tate J, Orozco M, et al. (2009) Association Between Pentavalent Rotavirus Vaccine and Severe Rotavirus Diarrhea Among Children in Nicaragua. Jama-Journal of the American Medical Association 301: 2243-2251.
7. Ludert JE, Ruiz MC, Hidalgo C, Liprandi F (2002) Antibodies to rotavirus outer capsid glycoprotein VP7 neutralize infectivity by inhibiting virion decapsidation. J Virol 76: 6643-6651. (Pubitemid 34633530)
8. WHO (2011) Global rotavirus information and surveillance bulletin. Reporting period: January through December 2010. World Health Organization 4.
9. Patton JT (2012) Rotavirus diversity and evolution in the post-vaccine world. Discov Med 13: 85-97.
10. Rahman M, Matthijnssens J, Yang X, Delbeke T, Arijs I, et al. (2007) Evolutionary history and global spread of the emerging g12 human rotaviruses. J Virol 81: 2382-2390.
11. Pant N, Marcotte H, Brussow H, Svensson L, Hammarstrom L (2007) Effective prophylaxis against rotavirus diarrhea using a combination of Lactobacillus rhamnosus GG and antibodies. BMC Microbiol 7: 86.
12. Pant N, Marcotte H, Hermans P, Bezemer S, Frenken L, et al. (2011) Lactobacilli producing bispecific llama-derived anti-rotavirus proteins in vivo for rotavirus-induced diarrhea. Future Microbiol 6: 583-593.
13. Ventola H, Lehtoranta L, Madetoja M, Simonen-Tikka ML, Maunula L, et al. (2012) Effects of the viability of Lactobacillus rhamnosus GG on rotavirus infection in neonatal rats. World J Gastroenterol 18: 5925-5931.
14. Szajewska H, Skorka A, Ruszczynski M, Gieruszczak-Bialek D (2013) Metaanalysis: Lactobacillus GG for treating acute gastroenteritis in children - updated analysis of randomised controlled trials. Aliment Pharmacol Ther.
15. Grandy G, Medina M, Soria R, Teran CG, Araya M (2010) Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children. BMC Infect Dis 10: 253.
16. Hamers-Casterman C, Atarhouch T, Muyldermans S, Robinson G, Hamers C, et al. (1993) Naturally occurring antibodies devoid of light chains. Nature 363: 446-448. (Pubitemid 23179389)
17. Harmsen MM, De Haard HJ (2007) Properties, production, and applications of camelid single-domain antibody fragments. Appl Microbiol Biotechnol 77: 13-22. (Pubitemid 47573319)
18. Tokuhara D, Alvarez B, Mejima M, Hiroiwa T, Takahashi Y, et al. (2013) Ricebased oral antibody fragment prophylaxis and therapy against rotavirus infection. J Clin Invest in press.
19. van der Vaart JM, Pant N, Wolvers D, Bezemer S, Hermans PW, et al. (2006) Reduction in morbidity of rotavirus induced diarrhoea in mice by yeast produced monovalent llama-derived antibody fragments. Vaccine 24: 4130-4137. (Pubitemid 44308223)
20. Pant N, Hultberg A, Zhao Y, Svensson L, Pan-Hammarstrom Q, et al. (2006) Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrhea. J Infect Dis 194: 1580-1588. (Pubitemid 44851901)
21. Martin MC, Pant N, Ladero V, Gunaydin G, Andersen KK, et al. (2011) Integrative expression system for delivery of antibody fragments by lactobacilli. Appl Environ Microbiol 77: 2174-2179.
22. Aladin F, Einerhand AW, Bouma J, Bezemer S, Hermans P, et al. (2012) In vitro neutralisation of rotavirus infection by two broadly specific recombinant monovalent llama-derived antibody fragments. PLoS One 7: e32949.
23. Ciarlet M, Conner ME (2000) Evaluation of rotavirus vaccines in small animal models. Methods Mol Med 34: 147-187.
24. Svensson L, Finlay BB, Bass D, von Bonsdorff CH, Greenberg HB (1991) Symmetric infection of rotavirus on polarized human intestinal epithelial (Caco-2) cells. J Virol 65: 4190-4197.
25. Perez-Arellano I, Zuniga M, Perez-Martinez G (2001) Construction of compatible wide-host-range shuttle vectors for lactic acid bacteria and Escherichia coli. Plasmid 46: 106-116. (Pubitemid 32980673)
26. Marcotte H, Koll-Klais P, Hultberg A, Zhao Y, Gmur R, et al. (2006) Expression of single-chain antibody against RgpA protease of Porphyromonas gingivalis in Lactobacillus. J Appl Microbiol 100: 256-263.
27. Andersen KK, Marcotte H, Alvarez B, Boyaka PN, Hammarstrom L (2011) In situ gastrointestinal protection against anthrax edema toxin by single-chain antibody fragment producing lactobacilli. BMC Biotechnol 11: 126.
28. Gunaydin G, Zhang R, Hammarstrom L, Marcotte H (2014) Engineered Lactobacillus rhamnosus GG expressing IgG-binding domains of protein G: Capture of hyperimmune bovine colostrum antibodies and protection against diarrhea in a mouse pup rotavirus infection model. Vaccine 32: 470-477.